what's trending

5 most popular innovation stories in Houston this week

Innovators to know and Houston events not to miss — plus other trending news from the week. Photo via Getty Images

Editor's note:Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included innovators to know, events not to miss, and more.

3 Houston innovators to know this week

This week's roundup of Houston innovators includes Amanda Ducach of ema, Bobby Bryant of DOSS, and Abbey Donnell of Work & Mother. Photos courtesy

In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from femtech to real estate — recently making headlines in Houston innovation. Read more.

Houston named No. 1 most stressful city for workers in U.S. in new report

Work life in H-Town is hard. Photo by Elisa Ventur on Unsplash

Feeling totally stressed about work? Fellow Houstonians feel the pain.

In a new report from LLC.org, Houston was designated the most stressful city to work in. In fact, not one — but five — Texas cities made the top 10 most stressful cities for workers. Ouch.

LLC.org’s analysis looked at eight different categories such as average commute time, average weekly hours worked, income growth rate, and more. Each of the 170-plus cities researched in the report have a population of at least 150,000 people – which adds up to a lot of stressed out folks nationwide.

Houston earned its most stressful city ranking due to its nearly 53-minute average round trip daily commute, not to mention that one in three people in the city are on the road before 7 am every morning. To top it off, Houston’s percentage of workers without health insurance is 30.4 percent, which is significantly higher than the national average of 10.5 percent.Read more.

Here's how many Texas jobs are at risk of being replaced by AI — according to AI

AI and automation are coming for Texas jobs, according to ChatGPT. Image via Getty Images

ChatGPT seems to have its eyes set on at least 200,000 Texas jobs, according to a new study.

The report by UK-based affiliate marketing site NetVoucherCodes compiled data on nearly 200 U.S. job types and then asked ChatGPT for each job’s relative risk from AI, automation, and also the likelihood of AI increasing that job’s productivity.

The query found that 237,000 jobs in Texas have a high risk of being replaced by AI, and 1.07 million jobs are considered at a medium risk of being replaced by AI. Read more.

10 can't-miss Houston business and innovation events for March

Here's your one-stop shop for innovation events in Houston for March. Photo via Getty Images

It's time to look at what's on the agenda for Houston innovators for the month of March — a busy one, from the end of Tech Rodeo and the start of CERAWeek, plus many more things to add to your calendars. Read more.

UK personalized surgery startup rebrands, expands to US by way of Houston

Insight Surgery is opening its first international location, and the UK company chose Houston for it. Photo via 3dlifeprints.com

An innovative health tech company headquartered in the United Kingdom has made its entrance into the United States — and Houston's Texas Medical Center is where it's setting up shop.

The company, newly renamed to Insight Surgery — neé 3D LifePrints — was originally established in 2011 by Paul Fotheringham as a social enterprise to create 3D printed prosthetics for amputees in Kenya. While the company still provides this care to developing countries, Fotheringham, who serves as CTO, evolved his mission into a business in 2015. The company is gearing up for its next evolution — starting with its first international expansion.

“We’re pivoting away from being a 3D printing company toward a company that personalizes surgery,” Fotheringham tells InnovationMap.

Insight Surgery's focus now is to provide digital planning for surgeons and create personalized medical devices. All the technology the company is working with is FDA approved, but will be customized for patients and surgeons. Previously, this type of customized care could take weeks or months, Fotheringham says, but with Insight Surgery's technology, they can accomplish this in a matter of days. Read more.

Trending News

Building Houston

 
 

now at the helm

Houston medical device startup names new CEO

Houston-based Saranas has tapped a new leader amidst push to commercialize bleed detection technology. Photo via LinkedIn

Houston-based medical device company Saranas has tapped a veteran of the healthcare industry as its new CEO.

Mike MacKinnon most recently was president and partner at Madison Ventures +, a private equity firm based in Greenwood Village, Colorado. The firm invests in companies in healthcare, real estate, finance, and other sectors.

Before joining Madison Ventures +, MacKinnon was CEO of Zidan Medical, a startup focused on treatment of airway lesions in patients with early stage lung cancer. He served in that role from 2019 to 2023.

Earlier, he was CEO of ROX Medical, a medical device company specializing in minimally invasive vascular therapy for patients with uncontrolled high blood pressure. He held that role from 2018 to 2019. He previously worked at Philips North America, Volcano, AtheroMed, Hansen Medical, Access Closure, and FoxHollow Technologies.

In a news release, Dan Wolterman, chairman of Saranas’ board and former president and CEO of Memorial Hermann Health System, calls MacKinnon “an accomplished executive with an impressive record of bringing disruptive technology to market, guiding strategy, and driving significant growth.”

Now president and CEO of Nashua, New Hampshire-based medical device company Conformal Medical, James Reinstein was president and CEO of Saranas from 2020 to 2022. Prior to Reinstein, Zaffer Syed held that position from 2017 to 2020. He's still an adviser for the company and recently announced his role as entrepreneur in residence at the Texas Medical Center.

Saranas is working on commercializing its Early Bird Bleed Monitoring System, touted as the first and only system FDA-approved bleeding detection system for procedures involving blood vessels. It is designed to detect bleeds early, enabling physicians to reduce medical risks and potentially avoid costly medical problems.

“Bleeding remains a common issue during and after endovascular procedures and can result in life-threatening complications,” says MacKinnon.

Since being founded in 2013, Saranas has treated over 1,200 patients with its device and has received $29.2 million in funding, according to Crunchbase. This includes a $12.8 million Series B round that Saranas got in 2021 from Chicago-based Baird Capital and Austin-based S3 Ventures.

The Early Bird device was developed at Houston’s Texas Heart Institute. The FDA approved the device in 2019.

Trending News